A murine model of accelerated periodontal disease in diabetes

Journal of Periodontal Research

Volumn 33, Issue 7, 1998, Pages 387-399

  Lalla, Evanthia ^a   Lamster, Ira B ^a   Feit, Michael ^a   Huang, Linda ^a   Schmidt, Ann Marie ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

Diabetes; Murine model; Periodontal disease; Porphyromonas gingivalis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; BACTERIUM ANTIBODY; COLLAGENASE; IMMUNOGLOBULIN RECEPTOR; STREPTOZOCIN;

ANIMAL; ARTICLE; BACTERIAL INFECTION; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; GINGIVA; IMMUNOLOGY; MALE; METABOLISM; MICROBIOLOGY; MOUSE; OSTEOLYSIS; PATHOGENICITY; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS;

ALVEOLAR BONE LOSS; ANIMALS; ANTIBODIES, BACTERIAL; BACTEROIDACEAE INFECTIONS; COLLAGENASES; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GINGIVA; GLYCOSYLATION END PRODUCTS, ADVANCED; MALE; MICE; MICE, INBRED C57BL; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS; RECEPTORS, IMMUNOLOGIC; STREPTOZOCIN;

EID: 0032174938     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1998.tb02335.x     Document Type: Article

References (63)

1. Cianciola L, Park B, Bruck E, Mosorich L, Genco RJ. Prevalence of periodontal disease in insulin-dependent diabetes mellitus. J Am Dem Assoc 1982; 104: 653-660.
2. Shlossman M, Knowler WC, Pettitt DJ, Genco RJ. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc 1990; 121: 531-536.
3. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in insulin-dependent diabetes mellitus. J Periodontol 1991; 62: 123 130.
4. Nelson RG, Shlossman M, Budding LM, et al. Periodontal disease and insulin-dependent diabetes mellitus in Pima Indians. Diabetes Care 1990; 13: 836-840.
5. Grossi SG, Zambon JJ, Ho AW, et al. Assessment for risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994; 65: 260-267.
6. Manouchehr-Pour M, Spagnuolo PJ, Rodman HM, Bissada NF. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. J Periodontol 1981; 52: 410-414.
7. McMullen JA, Van Dyke TE, Horoszewicz HU, Genco RJ. Neutrophil chemotaxis in individuals with advanced periodontal disease and a genetic predisposition to diabetes mellitus. J Periodontol 1981; 52: 167-173.
8. Nerup J, Mandrup-Poulsen T, Molvig J. The HLA-IDDM association: implications for etiology and pathogenesis of IDDM. Diabetes Metabol Rev 1987; 3: 779-802.
9. Ryan ME, Ramamurthy S, Golub LM. Matrix metallo-proteinases and their inhibition in periodontal treatment. Curr Opin Periodontol 1996; 3: 85-96.
10. Sasaki T, Ramamurthy NS, Yu Z, Golub LM. Tetracycline administration increases protein (presumably procollagen) synthesis and secretion in periodontal ligament fibroblasts of streptozotocin-induced diabetic rats. J Periodontal Res 1992; 27: 631-639.
11. 2 shows stable interindividual differences. Scand J Immunol 1988; 27: 705-716.
12. Salvi GE, Collins JG, Yalda B, Arnold RR, Lang NP, Offenbacher S. Monocytic TNF-alpha secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 1997; 24: 8-16.
13. Yalda B, Offenbacher S, Collins JG. Diabetes as a modifier of periodontal disease expression. Periodontol 2000 1994; 6: 37-49.
14. Ruderman N, Williamson J, Brownlee M. Glucose and diabetic vascular disease. FASEB J 1992; 6: 2905-2914.
15. Baynes J. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.
16. Sell D, Monnier V. Structure elucidation of a senescence cross-link from human extracellular matrix; implication of pentoses in the aging process. J Biol Chem 1989; 264: 21597-21602.
17. Schmidt AM, Weidman E, Lalla E, et al Advanced glycation endproducts induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodontal Res 1996; 31: 508-515.
18. Schmidt AM, Vianna M, Gerlach M, et al. Isolation and characterization of binding proteins for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface. J Biol Chem 1992; 267: 14987 14997.
19. Neeper M. Schmidt AM, Brett J, et al. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992; 267: 14998-15004.
20. Brett J, Schmidt AM. Zou YS, et al Tissue distribution of the receptor for advanced glycation endproducts (RAGE): expression in smooth muscle, cardiac myocytes. and neural tissue in addition to the vasculature. Am J Pathol 1993; 143: 1699-1712
21. Ritthaler U, Deng Y, Zhang Y, et al. Expression of receptors for advanced glycation endproducts in peripheral occlusive vascular disease. Am J Pathol 1995, 146: 688-694.
22. Schmidt AM, Yan SD, Stern D. The dark side of glucose (News and Views). Nat Med 1995; 1: 1002-1004.
23. Wautier JL, Zoukourian C, Chappey O, et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation endproducts blocks hyperpermeability. J Clin Invest 1996; 97: 238-243.
24. Schmidt AM, Hori O, Chen J, et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1): a potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 1995; 96: 1395-1403.236.
25. Schmidt AM, Yan SD, Brett J, Mora R, Stern D. Regulation of mononuclear phagocyte migration by cell surface binding proteins for advanced glycosylation endproducts. J Clin Invest 1993; 92: 2155-2168.
26. Schmidt AM, Hasu M, Popov D, et al. The receptor for advanced glycation endproducts (AGEs) has a central role in vessel wall interactions and gene activation in response to AGEs in the intravascular space. Proc Natl Acad Sci USA 1994; 91: 8807-8811.
27. 2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest 1996; 98: 1088-1094.
28. Evans RT, Klausen B, Ramamurthy NS, Golub LM, Seintescu C, Genco RJ Periodontopathic potential of two strains of Porphyromonas gingivalis in gnotobiotic rats. Arch Oral Biol 1992; 37: 813-819.
29. Chang KM, Ramamurthy NS, McNamara TF, et al. Tetracyclines inhibit Porphyromonas gingivalis-induced alveolar bone loss in rats by a non-antimicrobial mechanism. J Periodont Res 1994; 29: 242-249.
30. Lamster IB, Kaluszhner-Shapira I, Herrera-Abreu M, Sinha R, Grbic JT. Serum IgG antibody response to Actinobacillus actinomycetemcomitans and Porphyrornonas gingivalis: implications for periodontal diagnosis. J Clin Periodont 1998; 25: 510-516.
31. Hori O, Brett J, Slattery T, et al. The receptor for advanced glycation endproducts (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J Biol Chem 1995; 270: 25752-25761.
32. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 1994; 218: 325-329.
33. Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976; 193: 415-417.
34. Holt SC, Ebersole J, Felton J, Brunsvold M, Kornman KS. Implantation of Bacieriodes gingivalis in nonhuman primates initiates progression of periodontitis. Science 1988; 239: 55-57.
35. Caton J, Mota L, Gandini L, Laskaris B. Non-human primate models for testing the efficacy and safety of periodontal regeneration procedures. J Periodontol 1994; 65: 1143-1150.
36. Giannobile WV, Finkelman RD, Lynch SE. Comparison of canine and non-human primate animal models for periodontal regenerative therapy: results following a single administration of PDGF/IGF-1. J Periodontol 1994; 65: 1158-1168.
37. Van Dijk LJ, Jansen J, Pilot T. van der Weele LT. Artificial periodontal defects in beagle dogs. A clinical evaluation during 24 months. J Periodontol 1982; 53: 449-452.
38. Klausen B. Microbiological and immunological aspects of experimental periodontal disease in rats: a review article. J Periodontol 1991; 62: 59-73.
39. Baer PN, Lieberman JE. Observation of some genetic characteristics of the periodontium in three strains of inbred mice. Oral Surg, Oral Med Oral Path 1959; 12: 820-829.
40. Baer PN, Lieberman JE. Periodontal disease in six strains of inbred mice. J Dent Res 1960; 39: 215-225.
41. Shklar G, Person P. The pocket mouse. A unique model of periodontal disease. J Periodontol 1975; 46: 723-730.
42. Messer HH. Alveolar bone loss in a strain of mice. J Periodont Res 1980; 15: 193-205.
43. Johnson RB. Effects of experimental diabetes mellitus on alveolar bone loss in periodontal disease-susceptible mice. J Periodent Res 1985; 20: 307-316.
44. Gilbert AD, Sofaer JA. Host genotype, pathogenic challenge and periodontal bone loss in the mouse. Arch Oral Biol 1988; 33: 855-861.
45. Mouton C, Hommond PG, Slots J, Genco RJ. Serum antibodies to Bacteroides asaccharolyticus (Bacteroides gingivalis): relationship to age and periodontal disease. Infect Immun 1981; 31: 182-192.
46. Patters MR, Kornman KS. Serum antibodies to Bacteroides species in human periodontitis. J Periodont Res 1982; 17: 474-477.
47. Mooney J, Adonogianaki E, Kinane DF. Relative avidity of serum antibodies to putative periodontopathogens in periodontal disease. J Periodont Res 1993; 28: 444-450.
48. Robson HG, Vas SI. Resistance of mice to Salmonella typhimurium. J Infect Dis 1972; 126: 378-380.
49. Sadarangani C, Skamene E, Kongshaven PAL. Cellular basis for genetically-determined enhanced resistance of certain mouse strains to Listeriosis. Infect Immun 1980; 28: 381-386.
50. Lopez C. Genetics of natural resistance to herpes virus infections in mice. Nature 1975; 258: 152-153.
51. Rowlatt C, Chesterman FC, Sheriff MU. Lifespan, age changes and tumor incidence in an aging C57BL mouse colony. Lab Anim 1976; 10: 419-442.
52. Furney SK, Skinner PS, Farrer J, Orme IM. Activities of rifabutin, clarithromycin, and cthambutol against two virulent strains of Mycobacterium avium in a mouse model. Antimicrob Agents Chemother 1995; 39: 786-789.
53. Birkcdal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993; 28: 500-510.
54. Lamster IB, Celenti R, Ebersole JL. The relationship of serum IgG antibody titers to periodontal pathogens to indicators of the host response in crevicular fluid. J Clin Periodontol 1990; 17: 419-425.
55. Kinane DF, Mooney J, MacFarlane TW, McDonald M. Local and systemic antibody response to putative periodontopathogens in patients with chronic periodontitis: correlation with clinic indices. Oral Micriobiol Immunol 1993; 8: 65-68.
56. Mooney J, Kinane DF. Levels of specific immunoglobulin G to Porphyromonas gingivalis in gingival crevicular fluid are related to site disease status. Oral Micriobiol Immunol 1997; 12: 112-116.
57. Mooney J, Adonogianaki E, Riggio MP, Takahashi K, Haenan A, Kinane DF. Initial serum antibody tiler to Porphyromonas gingivalis influences development of antibody avidity and success of therapy for chronic periodontitis. Infect Immun 1995; 63: 3411-3416.
58. Lamster IB, Novak MJ. Host mediators in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. Crit Rev Oral Biol Med 1992; 3: 31-60.
59. Stashenko P, Jandinski JJ, Fujiyoshi P, et al .Tissue levels of bone resorptive cytokines in periodontal disease. J Periodontol 1991; 62: 504-509.
60. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993; 64: 432-444.
61. Reynold JJ, Meikle MC. Mechanisms of connective tissue matrix destruction in periodontitis. Periodontol 2000 1997; 14: 144-157.
62. Coleman D, Diabetes-obesity syndromes in mice. Diabetes (suppl) 1982; 31: 1-6.
63. Wyse B, Dulin W. The influence of age and dietary conditions on diabetes in the Db mouse. Diabetologia 1970; 6: 268-273.